I respect those looking for an exit and a payday, but personally I would hate to see A2M sell to anyone.
I would prefer to see them push scientific research into the A2 proposition.
It's a positive sign to see Nestlé and other companies sponsoring their own A2 research. But that very research is telling them that the majority of their own A1-containing product range is inferior. They are hopelessly conflicted and I'd hate to see A2M effectively neutered by becoming just another product in Nestle's stable, when they can still transform the market longer term.
A2M Price at posting:
$5.78 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)